NCT00596102View on ClinicalTrials.gov

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

CompletedOBSERVATIONAL
Enrollment

3,258

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2011

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

Japanese Encephalitis purified inactivated vaccine

Japanese Encephalitis purified inactivated vaccine

All Listed Sponsors
lead

Valneva Austria GmbH

INDUSTRY

NCT00596102 - Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51 | Biotech Hunter | Biotech Hunter